Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGBL2 | Q5U5Z8 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | XBP1 | P17861 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3140737 | 0.86 | CYP3A4 (0.44) | AGBL2ALDH1A1MAPK1SMN1; SMN2POLB | |
| SCHEMBL5356876 | 0.82 | CYP3A4 (0.35) | AGBL2SMN1; SMN2POLBCYP3A4ACHE | |
| SCHEMBL4060815 | 0.80 | POLB (0.43) | AGBL2ALDH1A1POLBCYP3A4MEN1 | |
| SCHEMBL3141709 | 0.79 | ESR1 (0.33) | — | |
| SCHEMBL28114010 | 0.77 | CYP3A4 (0.41) | AGBL2ALDH1A1MAPK1SMN1; SMN2POLB | |
| SCHEMBL16704262 | 0.77 | — | — | |
| SCHEMBL3146241 | 0.77 | RXRB (0.41) | ALDH1A1MAPK1SMN1; SMN2MEN1MAPT | |
| SCHEMBL3138059 | 0.77 | CYP3A4 (0.49) | ALDH1A1POLBCYP3A4ACHEMAPT | |
| SCHEMBL16709881 | 0.77 | — | — | |
| SCHEMBL5350749 | 0.74 | CYP3A4 (0.51) | ALDH1A1MAPK1SMN1; SMN2POLBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8466180-B2 | Insecticidal compounds | SYNGENTA CROP PROTECTION LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-8466180-B2 | Insecticidal compounds | SYNGENTA CROP PROTECTION LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-8466180-B2 | Insecticidal compounds | SYNGENTA CROP PROTECTION LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-20100076078-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA CORP PROTECTION, INC. (US) | 2010-03-25 | — | — | US | disclosed |
| US-20100076078-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA CORP PROTECTION, INC. (US) | 2010-03-25 | — | — | US | disclosed |
| EP-2069287-A1 | INSECTICIDAL COMPOUNDS | Syngeta Participations AG (CH) | 2009-06-17 | — | — | EP | disclosed |
| WO-2008031534-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2008-03-20 | — | — | WO | disclosed |
| WO-2008031534-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2008-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076078-A1 | INSECTICIDAL COMPOUNDS | ACHE, CHRM1, CHRM2 | AGBL2 3604/4885ALDH1A1 95/4885MAPK1 2788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.